Skip to main content
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
letter
. 2020 Apr 8;105(2):358–359. doi: 10.1016/j.jhin.2020.04.003

Disinfection of N95 respirators by ionized hydrogen peroxide during pandemic coronavirus disease 2019 (COVID-19) due to SARS-CoV-2

VCC Cheng a,b, S-C Wong b, GSW Kwan a, W-T Hui c, K-Y Yuen d,
PMCID: PMC7194585  PMID: 32277965

Sir,

Coronavirus disease 2019 (COVID-19) due to SARS-CoV-2 has been spreading globally, and the World Health Organization declared a pandemic on 11th March 2020 [1]. The number of confirmed cases was 693,224 with 33,106 (4.8%) deaths as of 30th March 2020. The overwhelming number of infected cases not only paralyses the healthcare system, but also poses a significant risk to healthcare workers (HCWs). In Hong Kong, we adopted a proactive infection control approach, escalating the response according to the rapidly evolving epidemiology to minimize the risk of nosocomial transmission [2,3]. However, limited supply of personal protective equipment (PPE), especially N95 respirators, remains a great challenge. Although we have already adopted extended use of N95 respirators in accordance with the US Centers for Disease Control and Prevention (CDC) [4], we have to prepare for the worst-case scenario of lacking a supply of N95 respirators.

Therefore, we attempted to disinfect N95 respirators using SteraMist Binary Ionization Technology solution delivered through a SteraMist Surface Unit, registered with the US Environmental Protection Agency [5]. The main constituent is 7.8% H2O2 solution, which is converted to ionized H2O2 (iHP) after passing through a cold plasma arc, and moves like a gas over the surfaces of N95 respirators. The by-product of iHP is oxygen and water in the form of humidity.

The experiment was conducted in a well-ventilated room with six air changes per hour inside a biosafety level 2 microbiology laboratory, with the operator wearing a coverall protective gown. Four N95 respirators (two 3M1870+ and two 3M1860s) were hung horizontally (facing outer and inner surfaces), and each was inoculated with 10 μL of three different concentrations of influenza A virus subtype H1N1 [1,000,000 50% of tissue culture infectious dose (TCID50) mL−1, 100,000 TCID50 mL−1 and 10,000 TCID50 mL−1] in the presence of 1% fetal calf serum to mimic organic soil contamination in the clinical setting to the outer and inner surfaces (i.e. 10,000 TCID50, 1000 TCID50 and 100 TCID50 per spot). iHP was sprayed three times in a ‘to-and-fro’ manner at a distance of 24 inches for a total of appropriately 6 s. The viruses were also applied in a similar manner to a cover glass that served as the control on a non-porous surface. N95 respirators inoculated with influenza A virus without disinfection were used as the positive control. One hour later, the pieces of N95 respirators with viral inoculation were cut out. The virus was eluted from the N95 respirators for viral culture in Madin-Darby Canine Kidney (MDCK) cells. Cytopathic changes of MDCK cells were observed daily for 7 days by light microscopy. None of the iHP-treated pieces of N95 respirators demonstrated cytopathic changes suggesting the presence of live influenza A virus (Table I ). The samples were subcultured again on MDCK cells for a further 7 days, and no cytopathic changes were observed; this was confirmed by lack of detection of influenza A antigen following immunofluorescence staining. This experiment showed that iHP could kill influenza A virus at moderate to high levels of inoculum. Influenza A virus was chosen for this study because it is an enveloped RNA virus that has similar virological characteristics as coronaviruses.

Table I.

Ionized hydrogen peroxide (iHP) disinfection of N95 respirators inoculated with influenza A virus subtype H1N1

Dose of virus inoculation per spot iHP spray
No iHP spray
1870+ outer surface 1870+ inner surface 1860s outer surface 1860s inner surface Cover glass 1870+ outer surface Cover glass
10,000 TCID50 No growth No growth No growth No growth No growth Growth Growth
1000 TCID50 No growth No growth No growth No growth No growth Growth Growth
100 TCID50 No growth No growth No growth No growth No growth No growth No growth
No virus No growth No growth No growth No growth No growth No growth No growth

TCID50, 50% of tissue culture infectious dose.

Disinfection of disposable PPE can be attempted whenever the supply is limited during pandemics [6,7]. Reuse of N95 respirators has been proposed by CDC [4], but this carries a risk of contamination and infection of HCWs. Disinfection of N95 respirators may provide an alternative option. The disinfection process is faster using SteraMist, a hand-held device, than the conventional platform, which uses a higher concentration of H2O2 vapour (30% – 35%) and requires concealment of the air ventilation system and longer cycle times. Ultraviolet germicidal irradiation has also been used for the disinfection of N95 respirators, but it has been shown to degrade polymers, leading to a small increase in particle penetration [8]. It is important to test the particulate filtration efficiency of N95 respirators to determine the maximum number of disinfection cycles regardless of the method of disinfection. HCWs should be reminded not to reuse N95 respirators immediately after disinfection. In this study, the level of H2O2 on the inner surface of N95 respirators was 0.6 ppm (below the safety limit of <1 ppm) at 2 h and undetectable at 3 h. The speed of H2O2 release from N95 respirators may be variable and affected by the air current. More importantly, HCWs should be well informed regarding the potential risk of exposure to other chemicals or inert ingredients which may persist in the porous material of N95 respirators. This may pose a dilemma to HCWs who need to balance the risk and benefit of reusing N95 respirators with or without disinfection. Further investigation into the disinfection of N95 respirators is warranted.

Acknowledgements

The authors wish to thank Dr H. Shane for sharing the disinfection protocol, and Mr B. Chan for providing SteraMist Binary Ionization Technology solution and the SteraMist Surface Unit.

Conflict of interest statement

None declared.

Funding sources

None.

References


Articles from The Journal of Hospital Infection are provided here courtesy of Elsevier

RESOURCES